Overview

Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
We perform this study to identity efficacy and safety of Daclatasvir and Asunaprevir in real practice.
Phase:
Phase 4
Details
Lead Sponsor:
Pusan National University Hospital